Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.
about
Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequencesPhosphorylation of the RNA polymerase II carboxyl-terminal domain by CDK9 is directly responsible for human immunodeficiency virus type 1 Tat-activated transcriptional elongationCoordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcriptionRecruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cellsModulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5RNA conformational changes in the life cycles of RNA viruses, viroids, and virus-associated RNAsCyclin Box Structure of the P-TEFb Subunit Cyclin T1 Derived from a Fusion Complex with EIAV TatStructural insights into the cyclin T1-Tat-TAR RNA transcription activation complex from EIAVTat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcriptionDSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongationTFIIH inhibits CDK9 phosphorylation during human immunodeficiency virus type 1 transcriptionMultiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infectionIdentification of a cyclin T-binding domain in Hexim1 and biochemical analysis of its binding competition with HIV-1 TatMolecular dynamics simulation and experimental verification of the interaction between cyclin T1 and HIV-1 Tat proteinsThe positive transcription elongation factor b is an essential cofactor for the activation of transcription by myocyte enhancer factor 2Dynamics of human immunodeficiency virus transcription: P-TEFb phosphorylates RD and dissociates negative effectors from the transactivation response elementP-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase IIA Role of RNA Helicase A in cis-Acting Transactivation Response Element-mediated Transcriptional Regulation of Human Immunodeficiency Virus Type 1.Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.The emerging role of long non-coding RNAs in HIV infection.Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication.Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.The human endogenous retrovirus K Rev response element coincides with a predicted RNA folding region.Tat-SF1 is not required for Tat transactivation but does regulate the relative levels of unspliced and spliced HIV-1 RNAsThe carboxyl-terminal domain of RNA polymerase II is phosphorylated by a complex containing cdk9 and infected-cell protein 22 of herpes simplex virus 1.Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse.Antiapoptotic function of Cdk9 (TAK/P-TEFb) in U937 promonocytic cells.Induction of TAK (cyclin T1/P-TEFb) in purified resting CD4(+) T lymphocytes by combination of cytokines.RNA polymerase II carboxy-terminal domain kinases: emerging clues to their function.Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.Ubiquitylation of Cdk9 by Skp2 facilitates optimal Tat transactivation.TAR RNA loop: a scaffold for the assembly of a regulatory switch in HIV replication.Loop-loop interaction of HIV-1 TAR RNA with N3'-->P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcriptionFlavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replicationTat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1.Attenuation of HIV-1 replication in primary human cells with a designed zinc finger transcription factor.Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation.Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.The molecular biology of bovine immunodeficiency virus: a comparison with other lentiviruses.
P2860
Q24537527-8CB6E4AE-35B5-46AC-AAA8-3BCC0AF27369Q24537588-D3DD6D01-0C9A-4B57-9C2F-183AB7B67A15Q24559797-F9642D1E-DA12-4D76-B1E9-3EBB7E2CF782Q24679559-5809FBD9-DD37-41ED-92DB-93ED83157DE5Q24808657-CAD3501A-DDFB-451C-8C8E-48FF6394FF77Q27490443-356EA388-FF2C-4128-B66F-005371C6A4FCQ27645094-C196488A-BFAD-4B50-B53E-3C965729CEDDQ27652984-6BD4E5D2-5914-4E86-A83E-8EEAAE10E8A2Q28116305-AF54F38A-1507-473C-A2B6-664A88610645Q28139929-A2218410-25E4-4F2F-BDDA-3F7052AF772EQ28188877-94277C27-E348-4871-8AED-E509B7A98C93Q28246872-DD6EB10A-82F1-40EE-A3F6-F3BF29934B6BQ28247078-2598BC8A-A9AF-44DC-9028-C404F9555CD2Q28544421-720B78E7-753E-4A67-AE84-3D0CE13E7AF4Q28595060-06185CE7-7FC5-407D-910F-F9C9462172C2Q28646726-DEACC62F-E33A-4A96-98B8-9B9FD0EA6BE7Q29620167-3642971E-C846-4FCA-817B-534B80A1659CQ30274626-03D74CB7-E739-4864-9027-96714D7264E3Q30350982-6967D390-9E43-4678-9254-EBD0E95FFFFAQ30377278-A7BA020F-C0BA-471F-980B-ED2D1D142B8BQ30962300-90E3F394-64D2-4E19-AECD-A04564D2099AQ33196801-34CAFB48-EA13-4626-8E02-BB54CBFC5FA1Q33292323-85A3CFEF-5B9F-4E0F-A9EE-C4D46394528DQ33455685-324DBBE4-B94C-41AB-9EBB-0B3D64C0C0C7Q33788934-1FE712DB-0946-4D8C-AE57-803648F2BCE6Q33815611-11EE14AE-E9D6-4850-B515-E882230E3CAAQ33836069-D54BDAA8-CB9C-455C-80EC-C6E87F14EC81Q33849629-72FECEF8-6A03-494F-B5FB-34963177FE8DQ33905060-43AADB7B-CD3C-4304-A7FA-3E07A6568AA9Q33910799-4AEB68C1-2F36-4F3B-8DAA-11DA59536850Q33930482-9858DCFE-A288-4557-9A89-FBE7DCECA53EQ34030432-8F124333-588C-41B6-847A-412DCCEA5946Q34075254-4A05435C-489A-4C57-93BF-F9617F14361BQ34082542-0FE3172B-0491-4D7F-83AF-707AD2EB1BBEQ34141571-D5DBAEB8-B9E2-4E03-B9F5-B76E11A9C6ABQ34161703-8B030F49-AE56-4F20-9D4D-29388633AEEBQ34291247-3CF0A314-7A4E-4D60-8403-48567EB958F4Q34362286-168FA04D-2256-4C0C-8E99-ECE75381FC88Q34387337-34DE886D-625C-4202-ABB3-90508C39388EQ34429580-BAF23CE0-E4A9-4FBF-8067-4BF35DFE8A54
P2860
Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.
@ast
Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.
@en
type
label
Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.
@ast
Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.
@en
prefLabel
Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.
@ast
Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.
@en
P2093
P356
P1433
P1476
Tat transactivation: a model for the regulation of eukaryotic transcriptional elongation.
@en
P2093
P304
P356
10.1006/VIRO.1999.9944
P407
P577
1999-11-01T00:00:00Z